Best Eye Vitamins Reviewed: Most Effective Vision Supplements That Work

Best Eye Vitamins Reviewed: Most Effective Vision Supplements That Work

Of all the organs in the body, your eyes are subject to daily stress due to the hyper-sensitive exposure of computer screens. With our entire day dedicated to gadgets, it suddenly became impossible to cut down on screen time without a back-up plan. However, one thing you can do to take care of your eye health is to take vision supplements.

Taking vision supplements with high doses of natural ingredients such as vitamin C, vitamin E, beta-carotene, omega-3 fatty acids, lutein, and zeaxanthin can greatly improve macular health.

Our research and writing team has found the best vitamins to protect against eye diseases.

Let's take a look at the best supplements for vision

Our team has tested several vision supplements to find the best nutritional supplements to help improve the health of your eyes. Read this article for the best eye vitamins on the market.

Before we go any further, let's take a look at the summary of each addition to the vision in the following table:

Zenith Labs Vision 20
This gluten-free, non-GMO visual supplement is manufactured in a GMP-certified and FDA-approved facility to ensure the highest purity and safety.

The Vision of the Performance Lab
This supplement contains essential vitamins and omega-3 fatty acids that support healthy eye function.

Lutenol visual support
With the powerful formula of this supplement, you may see an improvement in your overall eye health.

1MD Vision MD
This supplement provides your eyes with essential nutrients and antioxidants, improves vision and removes harmful toxins.

Nujena Vision + Support
From this supplement, you can get essential fatty acids that can help you improve your clear vision and visual acuity significantly.

Advanced Bionutritionals Advanced Vision Formula
This supplement can relieve eye strain and damage caused by screen exposure with clinically proven ingredients rich in antioxidants and nutrients.

PhytAge Labs Eagle Eye 911
This supplement can protect you from blind eye disease and temporary vision loss due to its powerful ingredients.

PureHealth Research Complete Vision Formula
With this app, you can get complete visual support to maintain optimal eye health over the long term.

Providence
This eye supplement harnesses the power of omega-3 fatty acids to improve your health so you don't suffer from eye problems.

View from above
This supplement can strengthen your eye muscles so they age more slowly and help improve eye health.

Editorial
This dietary supplement uses a powerful vision formula that delivers essential fatty acids to the eyes so you can reap many eye health benefits.

Vista net
This vision supplement can prevent blurry vision by providing your eyes with the vitamins they need to stay healthy.

Divine vision 12:00
This supplement can help both men and women improve eye health and enhance vision.

Zenith Labs Vision 20

Brief description of the product
Main ingredients: beta-carotene, zinc, lutein, zeaxanthin, rosehip, taurine, etc.
Servings Per Container: 30
Money Back Guarantee. 180 day money back guarantee
Price: from $49

Zenith Labs is one of the hottest brands in the healthcare industry. You can find doctor-made supplements at Zenith Labs. All supplements are manufactured in GMP certified facilities to ensure the highest quality.

Zenith Labs Vision 20 is a dietary supplement that provides powerful antioxidant support to provide users with enhanced protection against toxins. The advanced formula of this vision supplement provides daily users with essential eye vitamins and omega-3 fatty acids to improve vision.

Zenith Labs Vision 20 meets all National Institute of Ophthalmology guidelines for formulation strength. It has been shown to help prevent age-related macular degeneration (AMD), vision loss, and blindness.

For best results, you should take one capsule of this supplement daily.

The Vision of the Performance Lab

Brief description of the product
Main ingredients: lutein, zeaxanthin, blueberry extract, saffron, etc.
Servings Per Container: 30
Money Back Guarantee. 60 Day Money Back Guarantee
Price: from $39

Performance Lab uses revolutionary nutritional formulas to create supplements like never before. These technologies include CurcuWIN®, FloraGLO® and NutriGenesis®+ to name a few. All Performance Lab manufacturing facilities are FDA and NSF cGMP registered.

Performance Lab Vision is a non-GMO, vegan, artificial, gluten and soy free dietary supplement. This is one of several vision supplements in NutriCaps® that are infused with prebiotics for easier absorption and faster digestion.

Vision contains all the essential vitamins and omega-3 fatty acids needed to fully support human vision. If you take one capsule of this supplement daily, you may be able to prevent eye conditions such as age-related macular degeneration and vision loss.

This supplement can reduce oxidative stress in your eyes so you can enjoy clear vision even at night. With its unique formula, Performance Lab Vision supports overall eye health.

Lutenol visual support

Brief description of the product
Main ingredients: lutein, zeaxanthin, zinc, etc.
Servings Per Container: 30
Money back guarantee: 180 days
Price: $27.95

Lutenol Vision Support is manufactured by Vita Balance Inc., a leading health brand based in Virginia, USA. This company uses high quality ingredients to manufacture its supplements in a GMP certified, FDA registered facility under strict controls.

You can get powerful antioxidant support from Lutenol Vision Support. This vision supplement can reduce oxidative stress in your eyes by providing essential vitamins from lutein, zeaxanthin, and natural plant extracts.

This supplement may reduce the risk of eye conditions such as macular degeneration and loss of night vision. Lutenol can improve circulation in your body so you can enjoy better central vision overall.

Lutenol ingredients are clinically proven to nourish your eyes, protecting them from damage caused by harmful light rays.

1MD Vision MD

Brief description of the product
Key Ingredients: Vitamin E, lycopene, marigold, lutein, zeaxanthin, etc.
Servings Per Container: 30
Money Back Guarantee. 90 Day Money Back Guarantee
Price: $40

1MD Nutrition makes nutritional supplements formulated by physicians to provide consumers with reliable and effective results. This wellness brand combines science and nature to bring you the best in nutrition and fitness. He uses clinically researched ingredients in all of his supplements to support your overall health.

1MD VisionMD provides essential nutrients from eye vitamins to improve eye health. This vision supplement contains antioxidants that reduce eye strain so you don't suffer from macular degeneration, diabetic retinopathy and vision loss. As a result, many users consider it one of the best eye vitamins.

1MD Eye Health supplements are formulated according to National Eye Institute guidelines to ensure maximum safety for people. They do not contain abnormally high levels of ingredients to keep the macula healthy.

Nujena Vision + Support

Brief description of the product
Key Ingredients: Vitamin E, lutein and zeaxanthin.
Servings Per Container: 30
Money back guarantee: 30 days
Price: $35

Nugena is a global brand that brings a new approach to people's health. It is a natural supplement brand that follows industry standards in the production of all of its creations. Nuzena has a team of nutritionists, nutritionists and nutritionists who can also advise you on a healthy lifestyle.

Nuzena Vision Support+ is one of the best vision supplements that uses only clinically proven natural ingredients. This eye supplement contains essential omega-3 fatty acids and nourishing vitamins.

This supplement has been shown to slow the progression of eye diseases such as age-related macular degeneration in the early stages. Nugena supplements may help improve overall eye health by supporting visual function.

Advanced Bionutritionals Advanced Vision Formula

Brief description of the product
Key Ingredients: Citrus Bioflavonoid Complex, Zinc, Blueberry, etc.
Servings Per Container: 30
Money back guarantee: 90 days
Price: $69.95

Advanced Vision's advanced bionutrient formula can reduce eye strain and soothe tired eyes so you can continue your daily screen work. It can provide you with the eye vitamins you need to keep you nourished, so you won't be at risk for age-related macular degeneration (AMD), glaucoma, temporary vision loss, or optic nerve disease.

The formula of this supplement contains essential fatty acids that moisturize the eyes and promote the production of tears. The Advanced Vision formula is formulated in accordance with the National Eye Institute to ensure maximum safety and quality for users. This vision formula can reduce damage to your eyes caused by oversensitive blue light exposure.

Advanced Bionutritionals Visual Supplements are formulated with clinically researched ingredients to deliver powerful results for humans. This brand makes modern supplements designed by doctors. It has received positive feedback from hundreds of customers online.

PhytAge Labs Eagle Eye 911

Brief description of the product
Main ingredients: zinc, beta-carotene, lycopene, L-taurine, grape seeds.
Servings Per Container: 30
Money back guarantee: 90 days
Price: $69.95

PhytAge Labs Eagle Eye 911 improves visual acuity and contrast sensitivity in general users. It contains vitamins and beta-carotene that support vision and overall eye health.

This supplement can improve eyesight in just a few days after taking it. It can improve your central vision so you don't suffer from blurry vision. This supplement may help you keep your eyes healthy by reversing the damage caused by overexposure to blue light.

Eagle Eye 911 is formulated according to the National Eye Institute guidelines to provide a safe and effective formula for everyday use.

Eagle i911 is made in the USA on the most modern equipment. This brand is known for transparent transactions and fair manufacturing practices. All PhytAge Labs visual supplements are non-GMO and cruelty free.

PureHealth Research Complete Vision Formula

Brief description of the product
Key Ingredients: Zinc, blueberry, lutein, zeaxanthin, and more.
Servings Per Container: 30
Money back guarantee: 60 days
Price: $49

PureHealth Research is a popular health and wellness brand dedicated to creating science-based, doctor-approved natural products. Many brands in the industry are using this approach to improve the overall user experience.

PureHealth Research Complete Vision Formula contains eight powerful natural ingredients that organically support the health of your eyes. It can improve eyesight and greatly increase visual acuity. This advanced vision formula may contain essential fatty acids to support eye health.

PureHealth Research Complete Vision Formula prevents lens damage so you won't experience problems like macular degeneration or blurred vision.

This supplement is non-GMO, gluten-free, suitable for vegetarians and... . . It received several reviews from online users review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review review Sequential review Sequential review Sequential review Received Sequential review Received Sequential review Received Sequential review Sequential review Sequential review Sequential review Sequential review Sequential review Sequential review

provinces

Brief description of the product
main ingredient. Zinc Copper, Lutein
Quantity: 30
Data not available.
Price: $69.

Poprovicin can be used to treat eye infections, blindness, and vision loss. .... can ... can . . . . . . Bank may may may may... may....

The most modern and powerful 100-year-old pop music ........... ...........

maximum vision

Brief description of the product
main hint. Lutein, quercetin, blueberry, gorse flower ................................................ .. . ...
Quantity: 30
money back guarantee. from 60
Price: $69.

ICESight Media has several popups to improve your permanent... This add-on is a great way to prevent users from getting into trouble. doing, doing, doing, doing do do do do do do do do do do do do do do do do do do do do do do do do do do do

This very blue blue makes the eyeballs of a single poser sharper, sharper, pop, pop, pop, maybe, maybe. maybe maybe maybe maybe... Bank maybe... . maybe maybe maybe maybe... Bank maybe

revision

Brief description of the product
main ingredient. quercetin
Quantity: 30
money back guarantee. from 60
Price: $69.

You can get an idea using the same additional text, Revision People ........................... ......... . ... .. . . . . . . This kind of sutsutra sutsutra sutsutra from vit twitter can do everything in eyes eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye eye... can ... can . . . . . . The bank may may may may... may.... It is necessary to make this specific, detailed and reliable decision in the eyes of media users...

Blurred Vision is a revised version of Cervitmin for people with uncontrolled eye disease... .

the outlook is clear

Brief description of the product
root cause. Vitamin H
Quantity: 30
money back guarantee. from 60
Price: $79.

Vypastat kadŅ–shliŅ”liŅ” sututr parihapaharrary saizyzid sahabe gachesy gachest .. . Vista Clear can improve the health of users' eyes so that they can reduce blur and reduce any eye disease. ।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।

āĻāχ āϏāĻŽ্āĻĒূāϰāĻ•āϟি āφāĻĒāύাāϰ āϤীāĻ•্āώ্āĻŖāϤা āωāύ্āύāϤ āωāύ্āύāϤ āĻĒāϰিāώ্āĻ•াāϰ āĻāĻŦং āĻāĻŦং āĻ…āύুāĻ­āĻŦ āĻ…āύুāĻ­āĻŦ āĻ•āϰāϤে āĻ•āϰāϤে āĻĒাāϰে āĻĒাāϰে āĻĒাāϰে ।।।। ।।।। āĻĒাāϰে ।।।।।।।।।।।।।।।।।।। ।।।।। āĻĒাāϰে।।।।।।।

āϐāĻļ্āĻŦāϰিāĻ• 12

āĻĒāύ্āϝেāϰ āϏ্āĻŦāϞ্āĻĒ āĻŦিāĻŦāϰāύী
āĻŽূāϞ āωāĻĒাāĻĻাāύ: āĻ—াঁāĻĻা, āĻŦিāϞāĻŦেāϰি, āφāĻ™্āĻ—ুāϰেāϰ āĻŦীāϜ, āĻŽāϏুāϰ āĻŽāϏুāϰ, āĻŽāϟāϰāĻļুāϟি āĻ…āύ্āϝাāύ্āϝ āĻ…āύ্āϝাāύ্āϝ āĻ…āύ্āϝাāύ্āϝ
Number: 30
āĻŽাāύি-āĻŦ্āϝাāĻ• āĻ—্āϝাāϰাāύ্āϟি 180-āĻĻিāύ
Price: $69.

āφāĻĒāύি āϝāĻĻি āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ (amd) āĻšāĻ“āϝ়াāϰ āĻ•āĻŽাāϤে āĻĄিāĻ­াāχāύ āĻ­িāĻļāύ 12 āĻšāϞ āϜāύ্āϝ āϏেāϰা āĻāĻ•āϟি ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।। āĻāχ āϏāĻŽ্āĻĒূāϰāĻ•āϟিāϤে āĻŦিāϟা āĻŦিāϟা āϞুāϟেāχāύ āϞুāϟেāχāύ āĻŽāϤো āωāĻĒাāĻĻাāύ āϰāϝ়েāĻ›ে āϰāϝ়েāĻ›ে āϰāϝ়েāĻ›ে āφāĻĒāύাāϰ āφāĻĒāύাāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϰাāĻ–াāϰ āϰাāĻ–াāϰ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ। āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ।। āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ। āĻ…āĻĒāϰিāĻšাāϰ্āϝ

āĻĄিāĻ­াāχāύ āĻ­িāĻļāύ 12 āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āĻĒাāϰে ।। ।। āĻāϟি āĻ…āϤ্āϝāϧিāĻ• āφāϞোāϰ āĻāĻ•্āϏāĻĒোāϜাāϰেāϰ āϚোāĻ–েāϰ āĻĒেāĻļীāĻ—ুāϞিāϰ āĻ•্āώāϤিāĻ•ে āĻ•āϰāϤে āĻĒাāϰে ।।

āĻĄিāĻ­াāχāύ āĻ­িāĻļāύ 12 āϚোāĻ–েāϰ āϰোāĻ— āĻāĻŦং āĻŦāϝ়āϏ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻŽ্āϝাāĻ•ুāϞাāϰ āϰোāĻ— āĻĒ্āϰāϤিāϰোāϧ āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে ।।।।।।।।।।।।।।।।।।।।

āϰ্āϝাāĻ™্āĻ•িং āĻĢ্āϝাāĻ•্āϟāϰāĻ—ুāϞি āϏেāϰা āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āĻĒāϰিāĻĒূāϰāĻ•āĻ—ুāϞি āĻĒāϰিāĻĒূāϰāĻ•āĻ—ুāϞি āĻ•āϰāϤে āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ āĻ•āϰāϤাāĻŽ

āĻ…āύেāĻ• āĻĻৃāώ্āϟি āĻĻৈāύিāĻ• āĻŦ্āϝāĻŦāĻšাāϰāĻ•াāϰীāĻĻেāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽāϰ্āĻĨāύ āĻ•āϰাāϰ āĻĻাāĻŦি ।।।।।।।।।।। āϝাāχāĻšোāĻ•, āϏāĻŽāϏ্āϤ āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āĻ•াāϜ āĻ•āϰে āύা। āĻĢāϞāϏ্āĻŦāϰূāĻĒ, āφāĻŽাāĻĻেāϰ āϏেāϰা āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύ āϜāύ্āϝ āϜāύ্āϝ āĻŦেāĻļ āĻĒ্āϰাāϏāĻ™্āĻ—িāĻ• āϰ‌্āϝাāĻ™্āĻ•িং āĻĢ্āϝাāĻ•্āϟāϰ āĻ•āϰেāĻ›ে ।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।

āĻĒ্āϰাāĻ•ৃāϤিāĻ• āωāĻĒাāĻĻাāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰা āĻšāϝ়

āĻļুāϧুāĻŽাāϤ্āϰ āύিāϜেāϰ āĻĒ্āϰাāĻ•ৃāϤিāĻ• āϏāĻŽ্āĻĒূāϰāĻ• āύিāϰ্āĻŦাāϚāύ āύিāϰ্āĻŦাāϚāύ āĻ•āϰাāϰ āφāĻĒāύাāĻ•ে āĻāϟি āĻāϟি āύিāϝ়āĻŽ āύিāϝ়āĻŽ āĻ•āϰāϤে āĻ•āϰāϤে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে ।।।। āĻšāĻŦে ।।।।।।।।।।।।।।।।।।। ।।।।। āĻšāĻŦে।।।।।।। āĻĒ্āϰাāĻ•ৃāϤিāĻ• āωāĻĒাāĻĻাāύ āĻ•āϰে āĻ•āϰে āϝে āϏāĻŽ্āĻĒূāϰāĻ•āϟি āωāĻĻ্āĻĻীāĻĒāĻ• āωāĻĻ্āĻĻীāĻĒāĻ• āĻāĻŦং āĻ…্āϝাāϞাāϰ্āϜেāύ āĻŽুāĻ•্āϤ āφāĻĒāύাāϰ āφāĻĒāύাāϰ āĻ•োāύো āĻĒাāϰ্āĻļ্āĻŦāĻĒ্āϰāϤিāĻ•্āϰিāϝ়া āĻ•āϰāĻŦে āύা ।।। āύা āύা ।।।।।।।।। āύা ।।।। āύা ।।।।।।।।।। ।।।।।।।।।। āύা āύা ।।।।।। āύা āύা āύা ।।। āύা ।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।

āωāĻĒāϰে āωāϞ্āϞিāĻ–িāϤ āĻĻৃāώ্āϟি āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•ে āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•ে āĻ•āϰাāϰ āĻ•āϰাāϰ āĻĢāϰ্āĻŽুāϞেāĻļāύāĻ—ুāϞিāϤে āĻŦৈāϜ্āĻžাāύিāĻ•āĻ­াāĻŦে āĻŦৈāϜ্āĻžাāύিāĻ•āĻ­াāĻŦে āĻŦৈāϜ্āĻžাāύিāĻ•āĻ­াāĻŦে āϏāĻŽāϰ্āĻĨিāϤ āωāĻĒাāĻĻাāύāĻ—ুāϞি ।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।।। ।।।।।।।।।।।।।।।।।।।।।।।।। āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞিāϤে āϏাāϧাāϰāĻŖ āϏাāϧাāϰāĻŖ āϚোāĻ–েāϰ āĻŽāϧ্āϝে āĻ­িāϟাāĻŽিāύ āĻ­িāϟাāĻŽিāύ āϏি, āĻ­িāϟাāĻŽিāύ āĻĄি āĻ­িāϟাāĻŽিāύ āχ āχ āχ āĻāĻ—ুāϞি āύিāϰ্āĻĻিāώ্āϟ āϝা āφāĻĒāύাāϰ āϰোāĻ— āĻšāĻ“āϝ়াāϰ āĻুঁāĻ•ি āĻ•āĻŽাāϤে ।।।।।।।।।।।

āĻ…āύ্āϝাāύ্āϝ āϏাāϧাāϰāĻŖ āĻŽāϧ্āϝে āϰāϝ়েāĻ›ে āϰāϝ়েāĻ›ে -3 āĻĢ্āϝাāϟি āĻ…্āϝাāϏিāĻĄ āĻ…্āϝাāϏিāĻĄ (āĻŽাāĻ›েāϰ āϤেāϞ āϤেāϞ āĻ…্āϝাāϏিāĻĄ āĻ…্āϝাāϏিāĻĄ āĻ…্āϝাāϏিāĻĄ āĻ…্āϝাāϏিāĻĄ āĻ…্āϝাāϏিāĻĄ), āφāϞāĻĢা āϞিāĻĒোāχāĻ• āϞিāĻĒোāχāĻ•, āĻŦিāϟা āĻ•্āϝাāϰোāϟিāύ āĻāĻŦং āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ āϜেāĻ•্āϏাāύāĻĨিāύ

āĻ•াāϰ্āϝāĻ•াāϰিāϤা
āĻāĻ•āϟি āϚোāĻ–েāϰ āφāĻĒāύাāĻ•ে āĻŦāϰ্āϧিāϤ āϚোāĻ–েāϰ āωāĻĒāĻ­োāĻ— āĻ•āϰāϤে āĻ•āϰāϤে āĻĒ্āϰāĻĻাāύ āĻ•āϰāĻŦে āĻ•āϰāĻŦে।। āĻāϟি āφāĻĒāύাāĻ•ে āϰোāĻ— āϰোāĻ— āϝেāĻŽāύ, āϰাāϤেāϰ āĻĻৃāώ্āϟি āĻĻৃāώ্āϟি, āĻ—্āϞুāĻ•োāĻŽা āĻ—্āϞুāĻ•োāĻŽা āĻĻূāϰে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে āĻšāĻŦে

āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϏুāĻŦিāϧা āĻĒাāĻ“āϝ়াāϰ āĻĒাāĻļাāĻĒাāĻļি, āφāĻĒāύাāĻ•ে āĻ…āĻŦāĻļ্āϝāχ āĻ…āύ্āϝাāύ্āϝ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏুāĻŦিāϧা āϝেāĻŽāύ āωāύ্āύāϤ āĻ…āύাāĻ•্āϰāĻŽ্āϝāϤা, āύিāϝ়āĻŽিāϤ āϰāĻ•্āϤে āĻļāϰ্āĻ•āϰা āĻāĻŦং āωāϚ্āϚ āĻļāĻ•্āϤিāϰ āĻŽাāϤ্āϰা āĻĒেāϤে āĻšāĻŦে।

āϜাāϤীāϝ় āϚāĻ•্āώু āχāύāϏ্āϟিāϟিāωāϟেāϰ āϏুāĻĒাāϰিāĻļ āĻ…āύুāϏāϰāĻŖ āĻ•āϰা

āύ্āϝাāĻļāύাāϞ āφāχ āχāύāϏ্āϟিāϟিāωāϟ āĻĒ্āϰāϤিāϟি āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽ্āĻĒূāϰāĻ• āĻŦ্āϰ্āϝাāύ্āĻĄেāϰ āĻ…āύুāϏāϰāĻŖ āĻ•āϰা āωāϚিāϤ āϏুāĻĒাāϰিāĻļāĻ—ুāϞিāϰ āĻāĻ•āϟি āĻŦিāĻļāĻĻ āϤাāϞিāĻ•া āĻĒ্āϰāϏ্āϤুāϤ āĻ•āϰে। āχāύāϏ্āϟিāϟিāωāϟāϟি āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āĻĒāϰিāĻĒূāϰāĻ•āĻ—ুāϞিāϤে āĻ­িāϟাāĻŽিāύ āϝুāĻ•্āϤ āĻ•āϰা āĻĒ্āϰāϝ়োāϜāύ āϝাāϤে āĻŦ্āϝāĻŦāĻšাāϰāĻ•াāϰীāĻĻেāϰ āϜāύ্āϝ āφāϰāĻ“ āĻ•াāϰ্āϝāĻ•āϰ āĻāĻŦং āωāĻĒāĻ•াāϰী āĻšāϝ়।

āωāĻĒāϰে āϤাāϞিāĻ•াāĻ­ুāĻ•্āϤ āϏāĻŽāϏ্āϤ āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āϜাāϤীāϝ় āϚāĻ•্āώু āχāύāϏ্āϟিāϟিāωāϟ āϏুāĻĒাāϰিāĻļ āĻ…āύুāϏāϰāĻŖ āĻ•āϰে āĻĒ্āϰāĻŖāϝ়āύ āĻ•āϰা āĻšāϝ়।

āĻŦিāĻļুāĻĻ্āϧāϤা āĻŽাāύ
āĻŦৈāϜ্āĻžাāύিāĻ• āĻ—āĻŦেāώāĻŖা āĻ…āύুāϝাāϝ়ী, āύিāϰ্āĻĻিāώ্āϟ āĻ­িāϟাāĻŽিāύ āĻāĻŦং āĻ–āύিāϜ āωāĻĒাāĻĻাāύ āϚোāĻ–েāϰ āϰোāĻ— āĻĒ্āϰāϤিāϰোāϧে āϏাāĻšাāϝ্āϝ āĻ•āϰে। āĻŦ্āϝāĻŦāĻšাāϰāĻ•াāϰীāĻĻেāϰ āϏāϰ্āĻŦোāϚ্āϚ āύিāϰাāĻĒāϤ্āϤা āύিāĻļ্āϚিāϤ āĻ•āϰাāϰ āϜāύ্āϝ āωāĻĒāϰেāϰ āϤাāϞিāĻ•াāϰ āĻŦেāĻļিāϰāĻ­াāĻ— āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি GMP-āĻĒ্āϰāϤ্āϝāϝ়িāϤ āĻāĻŦং FDA-āύিāĻŦāύ্āϧিāϤ āϏুāĻŦিāϧাāĻ—ুāϞিāϤে āϤৈāϰি āĻ•āϰা āĻšāϝ়।

āĻāχ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āωāϚ্āϚ āĻŽাāϤ্āϰাāϝ় āωāĻĒাāĻĻাāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে āύা āĻ•াāϰāĻŖ āϏেāĻ—ুāϞি āĻŦ্āϝāĻŦāĻšাāϰāĻ•াāϰীāĻĻেāϰ āϜāύ্āϝ āĻ•্āώāϤিāĻ•াāϰāĻ• āĻšāϤে āĻĒাāϰে। āϤাāϰা āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•ে āĻ•াāϰ্āϝāĻ•āϰāĻ­াāĻŦে āωāύ্āύāϤ āĻ•āϰāϤে āϏāĻ িāĻ• āĻŽাāϤ্āϰাāϝ় 100% āĻĒ্āϰাāĻ•ৃāϤিāĻ• āωāĻĒাāĻĻাāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে।

āĻ•োāĻŽ্āĻĒাāύি āϏ্āϟ্āϝাāύ্āĻĄিং
āύিāϜেāϰ āϜāύ্āϝ āϚোāĻ–েāϰ āϏāĻŽ্āĻĒূāϰāĻ• āĻ•েāύাāϰ āϏāĻŽāϝ়, āĻļিāϞ্āĻĒে āĻāϰ āĻ…āĻŦāϏ্āĻĨাāύ āĻāĻŦং āĻ–্āϝাāϤি āĻĒ্āϰāϤিāώ্āĻ া āĻ•āϰāϤে āφāĻĒāύাāϰ āĻŦ্āϰ্āϝাāύ্āĻĄেāϰ āĻĒāϟāĻ­ূāĻŽিāϟি āĻĒুāĻ™্āĻ–াāύুāĻĒুāĻ™্āĻ–āĻ­াāĻŦে āĻĒāϰীāĻ•্āώা āĻ•āϰা āωāϚিāϤ। āωāĻĒāϰে āωāϞ্āϞিāĻ–িāϤ āĻŦেāĻļিāϰāĻ­াāĻ— āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽ্āĻĒূāϰāĻ• āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āĻāĻŦং āϏাāϧাāϰāĻŖ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āωāύ্āύāϤি āĻ•āϰে। āĻāĻ—ুāϞি āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻāĻŦং āϏুāϏ্āĻĨāϤাāϰ āĻ•্āώেāϤ্āϰে āϏāĻŦāϚেāϝ়ে āύাāĻŽী āĻŦ্āϰ্āϝাāύ্āĻĄāĻ—ুāϞি āĻĻ্āĻŦাāϰা āϤৈāϰি āĻ•āϰা āĻšāϝ়।

āĻāχ āϏāĻŽāϏ্āϤ āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āĻĻৃāĻĸ় āĻĢāϞাāĻĢāϞ āύিāĻļ্āϚিāϤ āĻ•āϰāϤে āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āϚিāĻ•িāϤ্āϏাāĻ—āϤāĻ­াāĻŦে āĻ—āĻŦেāώāĻŖা āĻ•āϰা āĻ­িāϟাāĻŽিāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে।

āĻ—্āϰাāĻšāĻ• āĻĒ্āϰāĻļংāϏাāĻĒāϤ্āϰ
āĻāĻ•āϟি āϚোāĻ–েāϰ āϏāĻŽ্āĻĒূāϰāĻ• āϝা āĻ•োāύো āχāϤিāĻŦাāϚāĻ• āĻ—্āϰাāĻšāĻ• āĻĒāϰ্āϝাāϞোāϚāύা āĻĒাāϝ়āύি āφāĻŽাāĻĻেāϰ āφāĻ—্āϰāĻš āύেāχ। āφāĻŽāϰা āĻŦিāĻļ্āĻŦাāϏ āĻ•āϰি āĻļāϤ āĻļāϤ āĻ—্āϰাāĻšāĻ•েāϰ āĻĒ্āϰāĻļংāϏাāĻĒāϤ্āϰ āϏāĻš āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āĻ•াāϰ্āϝāĻ•āϰāĻ­াāĻŦে āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•ে āϏāĻŽāϰ্āĻĨāύ āĻ•āϰāϤে āĻĒাāϰে āĻāĻŦং āϚাāĻ•্āώুāώ āϏāĻŽāϏ্āϝাāĻ—ুāϞি āϏāĻŽাāϧাāύ āĻ•āϰāϤে āĻĒাāϰে।

āĻŦিāϜ্āĻžাāύ āĻ•ীāĻ­াāĻŦে āϏেāϰা āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύেāϰ āωāĻĒাāĻĻাāύāĻ—ুāϞিāĻ•ে āĻĢিāϰিāϝ়ে āĻĻেāϝ়?
āφāĻĒāύি āϝāĻĻি āφāĻĒāύাāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āωāύ্āύāϤ āĻ•āϰাāϰ āϜāύ্āϝ āϚোāĻ–েāϰ āϏāĻŽ্āĻĒূāϰāĻ• āĻ–ুঁāϜāĻ›েāύ, āϤāĻŦে āĻŦিāϜ্āĻžাāύ āϏেāϰা āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύেāϰ āωāĻĒাāĻĻাāύāĻ—ুāϞিāĻ•ে āϏāĻŽāϰ্āĻĨāύ āĻ•āϰে āĻ•িāύা āϤা āϜাāύা āϏāĻšāϜ āύāϝ়। āĻ…āύেāĻ• āĻŦ্āϰ্āϝাāύ্āĻĄ āϤাāĻĻেāϰ āĻĒāϰিāĻĒূāϰāĻ• āϞেāĻŦেāϞāĻ—ুāϞিāϤে āĻ­িāϟাāĻŽিāύ āĻāĻŦং āĻ–āύিāϜāĻ—ুāϞিāϰ āĻāĻ•āϟি āĻĻীāϰ্āϘ āϤাāϞিāĻ•া āϤাāϞিāĻ•াāĻ­ুāĻ•্āϤ āĻ•āϰে - āĻ•িāύ্āϤু āĻāχāĻ—ুāϞি āĻ•ি āφāĻĒāύাāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āωāύ্āύāϤ āĻ•āϰāϤে āĻ•াāϜ āĻ•āϰে?

āĻ•িāĻ›ু āϏেāϰা āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύেāϰ āωāĻĒাāĻĻাāύāĻ—ুāϞি āϏāĻŽ্āĻĒāϰ্āĻ•ে āĻ—āĻŦেāώāĻŖাāϟি āĻ•ী āĻŦāϞে:

āϞুāϟেāχāύ
āϞুāϟেāχāύ āĻšāϞ āĻāĻ•āϟি āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ, āĻāĻ•āϟি āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āϝা āĻ…āύেāĻ• āĻĢāϞ āĻ“ āϏāĻŦāϜিāϤে āĻĒাāĻ“āϝ়া āϝাāϝ়। āĻāϟি āϚোāĻ–েāϰ āĻŽ্āϝাāĻ•ুāϞাāϤেāĻ“ āĻĒাāĻ“āϝ়া āϝাāϝ়, āϝা āĻ•েāύ্āĻĻ্āϰীāϝ় āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāϰ āϜāύ্āϝ āĻĻাāϝ়ী। āϞুāϟেāχāύ āĻĢ্āϰি āϰ‌্āϝাāĻĄিāĻ•েāϞ āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ–āĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে, āϝা āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ (AMD) āĻšāϤে āĻĒাāϰে। āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āϞুāϟেāχāύ āĻāĻāĻŽāĻĄি āĻāĻŦং āĻ›াāύি āϰোāĻ—েāϰ āĻুঁāĻ•ি āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে।

āĻāϟি āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āωāύ্āύীāϤ āĻ•āϰাāϰ āϜāύ্āϝ āĻŦিāĻ­িāύ্āύ āωāĻĒাāϝ়ে āĻ•াāϜ āĻ•āϰে। āĻĒ্āϰāĻĨāĻŽāϤ, āĻāϟি āϏূāϰ্āϝ āĻāĻŦং āĻ…āύ্āϝাāύ্āϝ āωāϤ্āϏ āĻĨেāĻ•ে āύীāϞ āφāϞো āĻļোāώāĻŖ āĻ•āϰে, āϚোāĻ–েāϰ āωāĻĒāϰ āĻāϰ āĻ•্āώāϤিāĻ•āϰ āĻĒ্āϰāĻ­াāĻŦ āĻ•āĻŽাāϝ়। āĻĻ্āĻŦিāϤীāϝ়āϤ, āĻāϟি āĻāĻ•āϟি āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āĻšিāϏাāĻŦে āĻ•াāϜ āĻ•āϰে āĻŽুāĻ•্āϤ āϰ্āϝাāĻĄিāĻ•েāϞāĻ—ুāϞিāĻ•ে āύিāϰāĻĒেāĻ•্āώ āĻ•āϰāϤে āϝা āϚোāĻ–েāϰ āĻ•োāώāĻ•ে āĻ•্āώāϤি āĻ•āϰāϤে āĻĒাāϰে।

āϤৃāϤীāϝ়āϤ, āĻāϟি āϰেāϟিāύাāϝ় āĻ­িāϟাāĻŽিāύ āĻ-āĻāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•āϰ āĻŽাāϤ্āϰা āĻŦāϜাāϝ় āϰাāĻ–āϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে, āϝা āĻ­াāϞো āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāϰ āϜāύ্āϝ āĻ…āϤ্āϝাāĻŦāĻļ্āϝāĻ•। āĻ…āĻŦāĻļেāώে, āϞুāϟেāχāύ āϜিāĻ™্āĻ• āĻāĻŦং āĻ“āĻŽেāĻ—া -3 āĻĢ্āϝাāϟি āĻ…্āϝাāϏিāĻĄেāϰ āĻŽāϤো āĻĒ্āϰāϝ়োāϜāύীāϝ় āĻĒুāώ্āϟি āϏāϰāĻŦāϰাāĻš āĻ•āϰে āĻ•োāώāĻ—ুāϞিāĻ•ে āϏুāϏ্āĻĨ āϰাāĻ–āϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে।

āĻāχ āϏুāĻŦিāϧাāĻ—ুāϞি āĻ›াāĻĄ়াāĻ“, āĻāĻāĻŽāĻĄি āĻŦা āĻ›াāύি āφāĻ•্āϰাāύ্āϤ āĻŦ্āϝāĻ•্āϤিāĻĻেāϰ āĻŽāϧ্āϝে āϞুāϟেāχāύ āϚাāĻ•্āώুāώ āϤীāĻ•্āώ্āĻŖāϤা āĻāĻŦং āĻŦৈāĻĒāϰীāϤ্āϝ āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āωāύ্āύāϤ āĻ•āϰāϤে āĻĻেāĻ–াāύো āĻšāϝ়েāĻ›ে। āĻāϟি āĻāĻ•āĻĻৃāώ্āϟি āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āĻ•āĻŽাāϤে āĻāĻŦং āϰাāϤেāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āĻŦাāĻĄ়াāϤেāĻ“ āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে। āĻāχ āĻ•াāϰāĻŖে, āϞুāϟেāχāύ āĻĒ্āϰাāϝ়āχ āϚোāĻ–েāϰ āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞিāϰ āĻŽāϧ্āϝে āĻāĻ•āϟি āĻĒ্āϰāϧাāύ āωāĻĒাāĻĻাāύ āĻšিāϏাāĻŦে āĻ…āύ্āϤāϰ্āĻ­ুāĻ•্āϤ āĻ•āϰা āĻšāϝ়।

āϜিāĻ•্āϏাāύāĻĨিāύ
Zeaxanthin āĻšāϞ āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ āϝা āĻĒ্āϰাāĻ•ৃāϤিāĻ•āĻ­াāĻŦে āĻĢāϞ āĻ“ āϏāĻŦāϜিāϤে āĻĒাāĻ“āϝ়া āϝাāϝ়। āĻāϟি āϏāĻŦāϚেāϝ়ে āωāϞ্āϞেāĻ–āϝোāĻ—্āϝāĻ­াāĻŦে āĻĒাāĻ“āϝ়া āϝাāϝ় āϝেāĻŽāύ āĻ•āĻŽāϞা, āĻŦেāϞ āĻŽāϰিāϚ, āĻ•াāϞে, āĻŽāϟāϰ, āĻ­ুāϟ্āϟা, āĻĄিāĻŽ āĻāĻŦং āĻĒেঁāĻĒে। āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻāϰ āĻŦিāϏ্āϤৃāϤ āϏুāĻŦিāϧাāϰ āĻ•াāϰāĻŖে āĻāϟিāĻ•ে āϏাāϧাāϰāĻŖāϤ "āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύ" āĻŦāϞা āĻšāϝ় - āĻŦিāĻļেāώ āĻ•āϰে āĻ›াāύি āĻāĻŦং AMD āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰাāϰ āĻ•্āώāĻŽāϤা।

āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āϏāĻŦāϚেāϝ়ে āωāϞ্āϞেāĻ–āϝোāĻ—্āϝ āϏুāĻŦিāϧা āϜেāĻ•্āϏাāύāĻĨিāύেāϰ āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āĻŦৈāĻļিāώ্āϟ্āϝ āĻĨেāĻ•ে āφāϏে। āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āĻāχ āĻĒুāώ্āϟিāϰ āύিāϝ়āĻŽিāϤ āϏেāĻŦāύ āϞেāύ্āϏāĻ•ে āĻĢ্āϰি āϰ‌্āϝাāĻĄিāĻ•েāϞ āĻĨেāĻ•ে āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āϏ্āϟ্āϰেāϏেāϰ āĻ•্āώāϤি āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে, āϝা āϏূāϰ্āϝেāϰ āĻ•্āώāϤি āĻĨেāĻ•ে āϧোঁāϝ়া āĻŦা āχāωāĻ­ি āĻāĻ•্āϏāĻĒোāϜাāϰেāϰ āĻŽāϤো āĻĒāϰিāĻŦেāĻļāĻ—āϤ āĻŦিāώাāĻ•্āϤ āĻĒāĻĻাāϰ্āĻĨ āĻĻ্āĻŦাāϰা āϤৈāϰি āĻ…āĻŖু।

āϚোāĻ–েāϰ āϞেāύ্āϏ āĻāĻŦং āϰেāϟিāύা āϤৈāϰি āĻ•āϰে āĻāĻŽāύ āĻ•োāώāĻ—ুāϞিāϤে āĻāχ āĻŽুāĻ•্āϤ āϰ্āϝাāĻĄিāĻ•েāϞāĻ—ুāϞি āĻĒৌঁāĻ›াāϤে āĻŦাāϧা āĻĻেāĻ“āϝ়াāϰ āĻŽাāϧ্āϝāĻŽে - āĻŽূāϞāϤ āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϜāύ্āϝ āϏাāύāϏ্āĻ•্āϰিāύেāϰ āĻŽāϤো āĻ•াāϜ āĻ•āϰে - āϜেāĻ•্āϏাāύāĻĨিāύ āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻāĻ•āϟি āĻļāĻ•্āϤিāĻļাāϞী āĻĒ্āϰāϤিāϰāĻ•্āώাāĻŽূāϞāĻ• āĻāϜেāύ্āϟ āĻšিāϏাāĻŦে āĻ•াāϜ āĻ•āϰে!

āϞাāχāĻ•োāĻĒেāύ
āϞাāχāĻ•োāĻĒিāύ āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻāĻ•āϟি āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻĒুāώ্āϟি āĻ•াāϰāĻŖ āĻāϟি āĻĢ্āϰি āϰ্āϝাāĻĄিāĻ•েāϞ āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ–āĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏāĻšাāϝ়āϤা āĻ•āϰে। āĻĢ্āϰি āϰ‌্āϝাāĻĄিāĻ•্āϝাāϞ āĻļāϰীāϰেāϰ āĻ•োāώেāϰ āĻ•্āώāϤি āĻ•āϰāϤে āĻĒাāϰে āĻāĻŦং āĻŦāϝ়āϏāϜāύিāϤ āϰোāĻ— āϝেāĻŽāύ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ āĻāĻŦং āĻ›াāύি āĻšāϤে āĻĒাāϰে।

āϞাāχāĻ•োāĻĒিāύেāϰ āϏংāĻŽিāĻļ্āϰāĻŖে āĻĻুāϟি āĻĒ্āϰāϧাāύ āωāĻĒাāĻĻাāύ āϰāϝ়েāĻ›ে: āĻŦিāϟা-āĻ•্āϝাāϰোāϟিāύ āĻāĻŦং āφāϞāĻĢা-āĻ•্āϝাāϰোāϟিāύ। āĻŦিāϟা-āĻ•্āϝাāϰোāϟিāύ āĻļāϰীāϰে āĻ­িāϟাāĻŽিāύ āĻ-āϤে āϰূāĻĒাāύ্āϤāϰিāϤ āĻšāϝ়, āϝা āϏুāϏ্āĻĨ āĻĻৃāώ্āϟি āĻŦāϜাāϝ় āϰাāĻ–āϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে। āφāϞāĻĢা-āĻ•্āϝাāϰোāϟিāύ UV āĻŦিāĻ•িāϰāĻŖ āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ– āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে। āϞাāχāĻ•োāĻĒিāύে āϰāϝ়েāĻ›ে āϞুāϟেāχāύ āĻāĻŦং āϜেāĻ•্āϏাāύāĻĨিāύ, āφāϰāĻ“ āĻĻুāϟি āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ āϝা āĻŦāϝ়āϏāϜāύিāϤ āϚোāĻ–েāϰ āϰোāĻ— āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে।

āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āĻĒ্āϰāϚাāϰ āĻ•āϰাāϰ āϏāĻŽāϝ়, āϞাāχāĻ•োāĻĒেāύ āĻĢ্āϰি āϰ‌্āϝাāĻĄিāĻ•েāϞ āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ–āĻ•ে āϰāĻ•্āώা āĻ•āϰে। āĻāχ āϏুāϰāĻ•্āώা āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āϚোāĻ–েāϰ āϰোāĻ— āϝেāĻŽāύ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ āĻāĻŦং āĻ›াāύি āĻšāĻ“āϝ়াāϰ āĻুঁāĻ•ি āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে।

āĻŦিāϟা āĻ•্āϝাāϰোāϟিāύ
āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝে āĻŦিāϟা-āĻ•্āϝাāϰোāϟিāύেāϰ āĻ•াāϰ্āϝāĻ•াāϰিāϤাāϰ āĻĒāĻ•্āώে āĻĒ্āϰāĻŽাāĻŖ āĻŦ্āϝাāĻĒāĻ•। āĻŦেāĻļ āĻ•িāĻ›ু āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āĻ–াāĻĻ্āϝāϤাāϞিāĻ•া āĻŦাāĻĄ়াāύো āĻŦা āĻŦিāϟা-āĻ•্āϝাāϰোāϟিāύেāϰ āϏাāĻĨে āϏāĻŽ্āĻĒূāϰāĻ• āĻ•āϰা āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāϰ āωāύ্āύāϤি āĻ•āϰে āĻāĻŦং āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ (AMD) āĻāϰ āĻুঁāĻ•ি āĻ•āĻŽাāϝ়।

AMD āĻāϰ āωāĻĒāϰ āĻāϰ āĻĒ্āϰāĻ­াāĻŦ āϏāĻŽ্āĻĒāϰ্āĻ•ে, āĻĻুāϟি āĻĒ্āϰāϧাāύ āĻ•্āϞিāύিāĻ•াāϞ āϟ্āϰাāϝ়াāϞ - āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āϚোāĻ–েāϰ āϰোāĻ— āĻ…āϧ্āϝāϝ়āύ (AREDS) āĻāĻŦং AREDS 2 - āĻĻেāĻ–াāϝ় āϝে āĻŦিāϟা āĻ•্āϝাāϰোāϟিāύেāϰ āĻĻৈāύিāĻ• āĻŽৌāĻ–িāĻ• āĻĄোāϜ āĻ—্āϰāĻšāĻŖ āĻ•āϰা āωāύ্āύāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻ…āĻŦāĻ•্āώāϝ়েāϰ āĻুঁāĻ•ি 25 āĻļāϤাংāĻļ āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে।

āĻĢāϞāϏ্āĻŦāϰূāĻĒ, āϚিāĻ•িāϤ্āϏāĻ•āϰা āĻāĻ–āύ 15 āĻŽিāϞিāĻ—্āϰাāĻŽ āϞুāϟেāχāύ, 230 āĻāĻŽāϏিāϜি āϜিāĻ•্āϏাāύāĻĨিāύ āĻāĻŦং 6 āĻŽিāϞিāĻ—্āϰাāĻŽ āĻŦিāϟা āĻ•্āϝাāϰোāϟিāύ āϏāĻŽ্āĻŦāϞিāϤ āĻāĻ•āϟি āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āϏāĻŽ্āĻĒূāϰāĻ• āĻĢāϰ্āĻŽুāϞেāĻļāύāĻ•ে āĻŦ্āϝাāĻĒāĻ•āĻ­াāĻŦে āϏāĻŽāϰ্āĻĨāύ āĻ•āϰেāύ āϝাāĻĻেāϰ āĻŽāϧ্āϝāĻŦāϰ্āϤী AMD āĻŦা āωāύ্āύāϤ AMD āĻĨেāĻ•ে āϏংāϰāĻ•্āώāĻŖ āĻ•āϰা āĻšāϝ়।

āϰোāϜ āĻšিāĻĒāϏ
āϰোāϜ āĻšিāĻĒāϏ āĻšāϞ āĻ—োāϞাāĻĒ āĻ—াāĻ›েāϰ āĻĢāϞ āĻāĻŦং āĻāĻ—ুāϞি āĻĻেāĻ–āϤে āĻ›োāϟ, āĻ—োāϞাāĻ•াāϰ āĻŦেāϰিāϰ āĻŽāϤো। āĻāĻ—ুāϞি āĻ­িāϟাāĻŽিāύ āϏি-āĻāϰ āĻāĻ•āϟি āϏāĻŽৃāĻĻ্āϧ āĻ‰ā§ŽāϏ, āϝা āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ। āĻ­িāϟাāĻŽিāύ āϏি āĻĢ্āϰি āϰ‌্āϝাāĻĄিāĻ•্āϝাāϞেāϰ āĻ•াāϰāĻŖে āĻšāĻ“āϝ়া āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ–āĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে, āϝা āĻ›াāύি āĻāĻŦং āĻ…āύ্āϝাāύ্āϝ āĻŦāϝ়āϏāϜāύিāϤ āϚোāĻ–েāϰ āϰোāĻ— āĻšāϤে āĻĒাāϰে।

āĻ—োāϞাāĻĒেāϰ āĻĒোঁāĻĻেāĻ“ āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ āϰāϝ়েāĻ›ে āϝেāĻŽāύ āϞুāϟেāχāύ āĻāĻŦং āϜেāĻ•্āϏাāύāĻĨিāύ, āϏ্āĻŦাāϏ্āĻĨ্āϝāĻ•āϰ āĻĻৃāώ্āϟি āĻŦāϜাāϝ় āϰাāĻ–াāϰ āϜāύ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ।

āωāĻĒāϰāύ্āϤু, āĻ—োāϞাāĻĒেāϰ āĻĒোঁāĻĻে āϰāϝ়েāĻ›ে āĻĢ্āϞ্āϝাāĻ­োāύāϝ়েāĻĄ āϝেāĻŽāύ āĻ•োāϝ়াāϰāϏেāϟিāύ āĻāĻŦং āϰুāϟিāύ, āϝাāϰ āĻŽāϧ্āϝে āĻĒ্āϰāĻĻাāĻš-āĻŦিāϰোāϧী āĻŦৈāĻļিāώ্āϟ্āϝ āϰāϝ়েāĻ›ে āϝা āϚোāĻ–েāϰ āĻĒ্āϰāĻĻাāĻš āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে। āĻ…āĻŦāĻļেāώে, āĻ—োāϞাāĻĒেāϰ āĻĒোঁāĻĻে āĻĒāϞিāĻĢেāύāϞ āĻĨাāĻ•ে āϝা āϚোāĻ–েāϰ āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āϏ্āϟ্āϰেāϏ āĻ•āĻŽাāϤে āĻāĻŦং āĻŽ্āϝাāĻ•ুāϞাāϰ āĻ…āĻŦāĻ•্āώāϝ় āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āĻĒাāϰে।

āĻāχ āϏāĻŽāϏ্āϤ āωāĻĒাāĻĻাāύ āϏাāĻŽāĻ—্āϰিāĻ• āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻāĻŦং āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝ āωāύ্āύীāϤ āĻ•āϰāϤে āĻāĻ•āϏাāĻĨে āĻ•াāϜ āĻ•āϰে।

āϟাāωāϰিāύ
Taurine āĻšāϞ āĻāĻ•āϟি āĻ…্āϝাāĻŽিāύো āĻ…্āϝাāϏিāĻĄ āϝা āĻļāϰীāϰে āĻĒ্āϰাāĻ•ৃāϤিāĻ•āĻ­াāĻŦে āĻĒাāĻ“āϝ়া āϝাāϝ় āϝা āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āĻāĻŦং āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻŦāϜাāϝ় āϰাāĻ–āϤে āĻ—ুāϰুāϤ্āĻŦāĻĒূāϰ্āĻŖ āĻ­ূāĻŽিāĻ•া āĻĒাāϞāύ āĻ•āϰে।

āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āϟৌāϰিāύ āϰেāϟিāύাāϞ āĻĒুāύāϰ্āϜāύ্āĻŽে āϏāĻšাāϝ়āϤা āĻ•āϰে āĻāĻŦং āĻ›াāύি āĻŦা āϚোāĻ–েāϰ āĻ…āύ্āϝাāύ্āϝ āϏāĻŽāϏ্āϝাāϰ āĻĒ্āϰাāĻĨāĻŽিāĻ• āĻĒāϰ্āϝাāϝ়ে āĻŽোāĻ•াāĻŦেāϞা āĻ•āϰা āĻŦ্āϝāĻ•্āϤিāĻĻেāϰ āϜāύ্āϝ āĻ…āϤিāϰিāĻ•্āϤ āϏāĻšাāϝ়āϤা āĻĒ্āϰāĻĻাāύ āĻ•āϰে āĻŦিāĻ­িāύ্āύ āϧāϰāĻŖেāϰ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻ…āĻŦāĻ•্āώāϝ় āĻĨেāĻ•ে āĻ­ুāĻ—āĻ›েāύ āĻāĻŽāύ āĻŦ্āϝāĻ•্āϤিāĻĻেāϰ āϜāύ্āϝ āϏāĻšাāϝ়āĻ• āĻšāϤে āĻĒাāϰে।

āĻāϟি āϚোāĻ–েāϰ āĻŽāϧ্āϝে āύāϤুāύ āĻ•োāώেāϰ āĻŦৃāĻĻ্āϧিāĻ•ে āωāĻĻ্āĻĻীāĻĒিāϤ āĻ•āϰāϤেāĻ“ āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে, āϝা āĻ—্āϞুāĻ•োāĻŽাāϰ āĻŽāϤো āϚোāĻ–েāϰ āĻ…āĻŦāϏ্āĻĨাāϰ āĻ•াāϰāĻŖে āĻĒ্āϰāĻĻাāĻš āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে।

āĻŽিāĻļিāĻ—াāύ āϏ্āϟেāϟ āχāωāύিāĻ­াāϰ্āϏিāϟিāϰ āĻāĻ•āϟি āϏāĻŽীāĻ•্āώাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āϟāϰিāύেāϰ āϏাāĻĨে āĻ–াāĻĻ্āϝāϤাāϞিāĻ•াāĻ—āϤ āĻĒāϰিāĻĒূāϰāĻ• AMD āφāĻ•্āϰাāύ্āϤ āĻŦ্āϝāĻ•্āϤিāĻĻেāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāĻ•ে āχāϤিāĻŦাāϚāĻ•āĻ­াāĻŦে āĻĒ্āϰāĻ­াāĻŦিāϤ āĻ•āϰে।

āϏāĻŽীāĻ•্āώাāϟিāĻ“ āωāĻĒāϏংāĻšাāϰে āĻāϏেāĻ›ে, "āĻāĻ•āϏাāĻĨে āύেāĻ“āϝ়া, āĻāχ āĻĢāϞাāĻĢāϞāĻ—ুāϞি āĻĒāϰাāĻŽāϰ্āĻļ āĻĻেāϝ় āϝে āĻ–াāĻĻ্āϝāϤাāϞিāĻ•াāĻ—āϤ āϟāϰিāύ āĻĒāϰিāĻĒূāϰāĻ• āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāϰ āωāĻĒāϰ āωāĻĒāĻ•াāϰী āĻĒ্āϰāĻ­াāĻŦ āĻĢেāϞāϤে āĻĒাāϰে।"

āϜাāĻĢāϰাāύ
āϜাāĻĢāϰাāύে āĻ•্āϰোāϏিāύ, āϏাāĻĢāϰাāύাāϞ āĻāĻŦং āĻĒিāĻ•্āϰোāĻ•্āϰোāϏিāύেāϰ āĻŽāϤো āϏāĻ•্āϰিāϝ় āωāĻĒাāĻĻাāύ āϰāϝ়েāĻ›ে। āωāĻĒāϰāύ্āϤু, āϜাāĻĢāϰাāύে āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ āϝেāĻŽāύ āϞুāϟেāχāύ āĻāĻŦং āϜেāĻ•্āϏাāύāĻĨিāύ āĻĒাāĻ“āϝ়া āĻ—েāĻ›ে, āϝা āϏুāϏ্āĻĨ āĻĻৃāώ্āϟি āĻŦāϜাāϝ় āϰাāĻ–াāϰ āϜāύ্āϝ āĻ…āĻĒāϰিāĻšাāϰ্āϝ।

āĻ•্āϰোāϏিāύ āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āϜাāĻĢāϰাāύেāϰ āϏāĻŦāϚেāϝ়ে āωāĻĒāĻ•াāϰী āωāĻĒাāĻĻাāύ āĻŦāϞে āĻŽāύে āĻ•āϰা āĻšāϝ়। āĻāϟি āĻāĻ•āϟি āĻ•্āϝাāϰোāϟিāύāϝ়েāĻĄ āϝা āϚোāĻ–āĻ•ে āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āĻ•্āώāϤি āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰে āĻāĻŦং āϚোāĻ–েāϰ āĻĒ্āϰāĻĻাāĻš āĻ•āĻŽাāϤেāĻ“ āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে। āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύ (AMD) āϰোāĻ—ীāĻĻেāϰ āĻŽāϧ্āϝে āĻ•্āϰোāϏিāύ āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āωāύ্āύāϤ āĻ•āϰāϤে āĻĒাāϰে।

Safranal āĻšāϞ āϜাāĻĢāϰাāύেāϰ āφāϰেāĻ•āϟি āϏāĻ•্āϰিāϝ় āωāĻĒাāĻĻাāύ āϝা āĻĒ্āϰāĻĻাāĻš-āĻŦিāϰোāϧী āĻŦৈāĻļিāώ্āϟ্āϝেāϰ āĻ…āϧিāĻ•াāϰী āĻĒাāĻ“āϝ়া āĻ—েāĻ›ে, āϝা āϚোāĻ–েāϰ āĻĒ্āϰāĻĻাāĻš āĻ•āĻŽাāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে। āĻāϟি āĻ›াāύি āĻāĻŦং āĻ…āύ্āϝাāύ্āϝ āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āϚোāĻ–েāϰ āϰোāĻ— āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤেāĻ“ āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে।

āĻĒিāĻ•্āϰোāĻ•্āϰোāϏিāύ āĻšāϞ āϜাāĻĢāϰাāύে āĻĒাāĻ“āϝ়া āĻāĻ•āϟি āϏāĻ•্āϰিāϝ় āϝৌāĻ— āϝা āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āĻŦৈāĻļিāώ্āϟ্āϝ āϧাāϰāĻŖ āĻ•āϰে āϝা āĻŦিāύাāĻŽূāϞ্āϝে āϰ্āϝাāĻĄিāĻ•েāϞ āĻĻ্āĻŦাāϰা āϏৃāώ্āϟ āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āĻ•্āώāϤি āĻĨেāĻ•ে āϚোāĻ–āĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে।

āĻ—াঁāĻĻা
āϏাāĻŽ্āĻĒ্āϰāϤিāĻ• āĻ—āĻŦেāώāĻŖাāϝ় āĻĻেāĻ–া āĻ—েāĻ›ে āϝে āĻ—াঁāĻĻা āϰাāϤেāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤি āωāύ্āύāϤ āĻ•āϰāϤে, āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āϚোāĻ–েāϰ āϰোāĻ— āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে, āϚোāĻ–েāϰ āϞাāϞāĻ­াāĻŦ āĻāĻŦং āϜ্āĻŦাāϞা āĻ•āĻŽাāϤে, āĻ…āĻļ্āϰু āĻ‰ā§ŽāĻĒাāĻĻāύāĻ•ে āωāĻĻ্āĻĻীāĻĒিāϤ āĻ•āϰāϤে āĻāĻŦং āĻ…āĻ•্āϏিāĻĄেāϟিāĻ­ āϏ্āϟ্āϰেāϏ āĻĨেāĻ•ে āϰāĻ•্āώা āĻ•āϰāϤে āϏাāĻšাāϝ্āϝ āĻ•āϰāϤে āĻĒাāϰে।

āϚāĻ•্āώু āĻ—āĻŦেāώāĻŖাāϝ় āĻĒ্āϰāĻ•াāĻļিāϤ 2013 āϏাāϞেāϰ āĻāĻ•āϟি āĻ—āĻŦেāώāĻŖাāϝ়, āĻ—āĻŦেāώāĻ•āϰা āĻāĻ• āĻŽাāϏ āĻ—াঁāĻĻা āĻĢুāϞেāϰ āύিāϰ্āϝাāϏেāϰ āĻāĻ•āϟি āĻ•্āĻŦাāĻĨ āĻĒাāύ āĻ•āϰাāϰ āĻĒāϰ 24 āϜāύ āϏুāϏ্āĻĨ āϏ্āĻŦেāϚ্āĻ›াāϏেāĻŦীāϰ āĻĻৃāώ্āϟিāĻļāĻ•্āϤিāϰ āĻŽূāϞ্āϝাāϝ়āύ āĻ•āϰেāĻ›েāύ। āϤাāϰা āĻĻেāĻ–āϤে āĻĒেāϝ়েāĻ›ে āϝে āĻĒ্āϞাāϏিāĻŦো āĻ—্āϰুāĻĒেāϰ āϏাāĻĨে āϤুāϞāύা āĻ•āϰাāϰ āϏāĻŽāϝ় āϚাāĻ•্āώুāώ āϤীāĻ•্āώ্āĻŖāϤা āωāϞ্āϞেāĻ–āϝোāĻ—্āϝāĻ­াāĻŦে āωāύ্āύāϤ āĻšāϝ়েāĻ›ে।

āϰেāϟিāύাāϞ āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āĻĒāϰিāĻŽাāĻĒেāϰ āĻ…āύ্āϧāĻ•াāϰ āĻ…āĻ­িāϝোāϜāύ āĻĒāϰীāĻ•্āώাāϰ āϏāĻŽāϝ়, āĻ…ংāĻļāĻ—্āϰāĻšāĻŖāĻ•াāϰীāϰা āĻŽাāχāĻ•্āϰো-āĻ•āύāϟ্āϰাāϏ্āϟ āϏংāĻŦেāĻĻāύāĻļীāϞāϤা āĻāĻŦং āĻ…āύ্āϧāĻ•াāϰ āĻ…āĻ­িāϝোāϜāύ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়াāϰ āωāύ্āύāϤিāĻ“ āωāϞ্āϞেāĻ– āĻ•āϰেāĻ›েāύ।

āĻĻৃāώ্āϟি āĻāĻŦং āĻĒāϰিāĻĒূāϰāĻ• āϏāĻŽ্āĻĒāϰ্āĻ•ে āĻĒ্āϰাāϝ়āĻļāχ āωāϤ্āϤāϰ āĻĻেāĻ“āϝ়া āĻĒ্āϰāĻļ্āύাāĻŦāϞী

āφāĻŽāϰা āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽ্āĻĒূāϰāĻ• āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻāχ āĻŦিāĻ­াāĻ—েāϰ āϏāĻŦāϚেāϝ়ে āϏাāϧাāϰāĻŖ āĻĒ্āϰāĻļ্āύেāϰ āωāϤ্āϤāϰ āĻĻিāϝ়েāĻ›ি।

āĻĒ্āϰāĻļ্āύঃ āϚোāĻ–েāϰ āĻ­িāϟাāĻŽিāύ āĻ•িāĻ­াāĻŦে āĻ•াāϜ āĻ•āϰে?
āωāϤ্āϤāϰ: āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āϜāύ্āϝ āĻŽূāϞ্āϝāĻŦাāύ āĻŦিāĻŦেāϚিāϤ āĻ­িāϟাāĻŽিāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে। āĻāĻ—ুāϞি āφāĻĒāύাāϰ āϚোāĻ–āĻ•ে āĻĒুāώ্āϟ āĻ•āϰে āĻāĻŦং āφāĻĒāύাāĻ•ে āϚোāĻ–েāϰ āϏāĻŽāϏ্āϝা āĻšāϤে āĻŦাāϧা āĻĻেāϝ়।

āĻĒ্āϰāĻļ্āύ: āĻ­িāϟাāĻŽিāύ āϏি āĻ•ি āĻĒ্āϰাāĻĨāĻŽিāĻ• āĻĒāϰ্āϝাāϝ়ে āĻŦāϝ়āϏ-āϏāĻŽ্āĻĒāϰ্āĻ•িāϤ āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύেāϰ āĻ…āĻ—্āϰāĻ—āϤিāĻ•ে āϧীāϰ āĻ•āϰāϤে āĻĒাāϰে?
āωāϤ্āϤāϰ: āĻĒ্āϰাāĻĨāĻŽিāĻ• āĻĒāϰ্āϝাāϝ়ে āĻŽ্āϝাāĻ•ুāϞাāϰ āĻĄিāϜেāύাāϰেāĻļāύেāϰ āĻ…āĻ—্āϰāĻ—āϤি āϏীāĻŽাāĻŦāĻĻ্āϧ āĻ•āϰাāϰ āϜāύ্āϝ āĻ­িāϟাāĻŽিāύ āϏি āĻŦেāĻļ āĻ•āϝ়েāĻ•āϟি āĻŦৈāϜ্āĻžাāύিāĻ• āĻ—āĻŦেāώāĻŖাāϝ় āĻĒ্āϰāĻŽাāĻŖিāϤ āĻšāϝ়েāĻ›ে। āĻĢāϞāϏ্āĻŦāϰূāĻĒ, āϤাāϰা āĻ…āύেāĻ• āĻŦিāĻ–্āϝাāϤ āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āĻĒাāĻ“āϝ়া āϝাāϝ়।

āĻĒ্āϰāĻļ্āύ: āĻāĻ•āϟি āϏুāώāĻŽ āĻ–াāĻĻ্āϝ āĻ…āύুāϏāϰāĻŖ āĻ•ি āĻĻৃāώ্āϟি āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏāĻŽāϰ্āĻĨāύ āĻ•āϰে?
āωāϤ্āϤāϰ: āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝ āĻŦাāĻĄ়াāύোāϰ āϜāύ্āϝ āφāĻĒāύাāϰ āϏুāώāĻŽ āĻ–াāĻĻ্āϝেāϰ āϏাāĻĨে āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āĻ—্āϰāĻšāĻŖāĻ•ে āϏāĻŽāϰ্āĻĨāύ āĻ•āϰা āωāϚিāϤ।

āĻĒ্āϰāĻļ্āύ: āĻ•িāĻ­াāĻŦে āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āφāĻĒāύাāϰ āϏাāĻŽāĻ—্āϰিāĻ• āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āωāύ্āύāϤি āĻ•āϰāϤে āĻĒাāϰে?
āωāϤ্āϤāϰ: āĻĻৃāώ্āϟি āϏāĻŽāϏ্āϝা āϏāĻŽাāϧাāύ āĻ›াāĻĄ়াāĻ“, āĻ•িāĻ›ু āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āφāĻĒāύাāĻ•ে āĻāĻ•াāϧিāĻ• āϏ্āĻŦাāϏ্āĻĨ্āϝ āϏুāĻŦিāϧা āĻĒ্āϰāĻĻাāύ āĻ•āϰāϤে āĻĒাāϰে, āϝেāĻŽāύ āωāύ্āύāϤ āϜ্āĻžাāύ, āωāϚ্āϚ āĻļāĻ•্āϤিāϰ āĻŽাāϤ্āϰা āĻāĻŦং āύিāϝ়āĻŽিāϤ āϰāĻ•্āϤে āĻļāϰ্āĻ•āϰাāϰ āĻŽাāϤ্āϰা।

āĻĒ্āϰāĻļ্āύ: āĻ­িāĻļāύ āϏাāĻĒ্āϞিāĻŽেāύ্āϟে āĻĒাāĻ“āϝ়া āϏāĻŦāϚেāϝ়ে āϏাāϧাāϰāĻŖ āωāĻĒাāĻĻাāύāĻ—ুāϞি āĻ•ী āĻ•ী?
āωāϤ্āϤāϰ: āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞিāϰ āϏāϰ্āĻŦাāϧিāĻ• āϏাāϧাāϰāĻŖ āĻĒ্āϰাāĻ•ৃāϤিāĻ• āωāĻĒাāĻĻাāύāĻ—ুāϞিāϰ āĻŽāϧ্āϝে āϰāϝ়েāĻ›ে āĻŦিāϟা āĻ•্āϝাāϰোāϟিāύ, āĻ­িāϟাāĻŽিāύ āϏি, āĻ­িāϟাāĻŽিāύ āχ, āφāϞāĻĢা āϞাāχāĻĒোāχāĻ• āĻ…্āϝাāϏিāĻĄ, āĻ…āĻĒāϰিāĻšাāϰ্āϝ āĻĢ্āϝাāϟি āĻ…্āϝাāϏিāĻĄ, āϞুāϟেāχāύ āĻāĻŦং āϜেāĻ•্āϏাāύāĻĨিāύ।

āĻĒ্āϰāĻļ্āύ: āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞিāϰ āωāϚ্āϚ āĻŽাāϤ্āϰা āĻ•ি āĻ•োāύ āĻĒাāϰ্āĻļ্āĻŦ āĻĒ্āϰāϤিāĻ•্āϰিāϝ়া āϏৃāώ্āϟি āĻ•āϰāϤে āĻĒাāϰে?
āωāϤ্āϤāϰ: āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•েāϰ āωāϚ্āϚ āĻŽাāϤ্āϰাāϝ় āύিāϰ্āĻĻিāώ্āϟ āĻ­িāϟাāĻŽিāύ āĻ—্āϰāĻšāĻŖ āĻ•āϰāϞে āφāĻĒāύাāϰ āĻļāϰীāϰে āĻĒাāϰ্āĻļ্āĻŦāĻĒ্āϰāϤিāĻ•্āϰিāϝ়া āĻšāϤে āĻĒাāϰে, āϝেāĻŽāύ āĻŽাāĻĨা āϘোāϰা, āĻŽাāĻĨাāĻŦ্āϝāĻĨা āχāϤ্āϝাāĻĻি।

āĻĒ্āϰāĻļ্āύ: āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āωāύ্āύāϤিāϰ āĻ•িāĻ›ু āĻĒ্āϰাāĻ•ৃāϤিāĻ• āωāĻĒাāϝ় āĻ•ী āĻ•ী?
āωāϤ্āϤāϰ: āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āĻĒāϰিāĻĒূāϰāĻ• āĻ—্āϰāĻšāĻŖ āĻ•āϰা āĻ›াāĻĄ়াāĻ“, āφāĻĒāύি āωāϞ্āϞিāĻ–িāϤ āĻŦিāώāϝ়āĻ—ুāϞি āĻ…āύুāϏāϰāĻŖ āĻ•āϰে āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āωāύ্āύāϤি āĻ•āϰāϤে āĻĒাāϰেāύ:

  • āϝāĻ–āύ āφāĻĒāύি UV āϰāĻļ্āĻŽিāϰ āϏংāϏ্āĻĒāϰ্āĻļে āφāϏেāύ āϤāĻ–āύ āĻĒ্āϰāϤিāϰāĻ•্āώাāĻŽূāϞāĻ• āϚāĻļāĻŽা āĻĒāϰিāϧাāύ āĻ•āϰুāύ
  • āφāĻĒāύাāϰ āϏ্āĻ•্āϰীāύ āϟাāχāĻŽ āĻ•āĻŽিāϝ়ে āĻĻিāύ āϝাāϤে āφāĻĒāύাāϰ āϚোāĻ–ে āĻ•্āώāϤিāĻ•াāϰāĻ• āύীāϞ āύা āφāϏে
  • āφāĻŦāĻ›া āφāϞোāϤে āĻ•āĻŽ্āĻĒিāωāϟাāϰেāϰ āĻĒāϰ্āĻĻা āĻĻেāĻ–āĻŦেāύ āύা
  • āĻĒুāώ্āϟি, āĻĒ্āϰোāϟিāύ āĻāĻŦং āĻ…্āϝাāύ্āϟিāĻ…āĻ•্āϏিāĻĄেāύ্āϟ āϏāĻŽৃāĻĻ্āϧ āϏুāώāĻŽ āĻ–াāĻŦাāϰ āĻ–াāύ

āϏেāϰা āĻĻৃāώ্āϟি āĻĒāϰিāĻĒূāϰāĻ• āϚূāĻĄ়াāύ্āϤ āϰাāϝ়

āĻĒ্āϰাāĻ•ৃāϤিāĻ•āĻ­াāĻŦে āφāĻĒāύাāϰ āϚোāĻ–েāϰ āϏ্āĻŦাāϏ্āĻĨ্āϝেāϰ āωāύ্āύāϤি āĻ•āϰāϤে āφāĻĒāύি āĻĒ্āϰāϤিāĻĻিāύ āĻ–েāϤে āĻĒাāϰেāύ āĻāĻŽāύ āĻ…āύেāĻ•āĻ—ুāϞি āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āϰāϝ়েāĻ›ে। āφāĻĒāύি āϏāϰ্āĻŦোāϚ্āϚ āĻļিāϞ্āĻĒ āĻŽাāύ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰে āĻĒ্āϰāĻŖāϝ়āύ āωāĻĒāϰোāĻ•্āϤ āϏেāϰা āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ• āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰāϤে āĻĒাāϰেāύ।

āφāĻĒāύি āϝāĻĻি āĻāχ āĻĻৃāώ্āϟি āϏāĻŽ্āĻĒূāϰāĻ•āĻ—ুāϞি āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰাāϰ āĻŦিāώāϝ়ে āϏāύ্āĻĻিāĻšাāύ āĻšāύ āϤāĻŦে āϏেāĻ—ুāϞি āĻ–াāĻ“āϝ়াāϰ āφāĻ—ে āφāĻĒāύাāϰ āϞাāχāϏেāύ্āϏāĻĒ্āϰাāĻĒ্āϤ āϏ্āĻŦাāϏ্āĻĨ্āϝāϏেāĻŦা āĻĒ্āϰāĻĻাāύāĻ•াāϰীāϰ āϏাāĻĨে āĻĒāϰাāĻŽāϰ্āĻļ āĻ•āϰা āωāϚিāϤ।

āĻ…āϧিāĻ­ুāĻ•্āϤ āĻĒ্āϰāĻ•াāĻļ:

āĻāχ āĻĒ্āϰোāĻĄাāĻ•্āϟ āϰিāĻ­িāωāϤে āĻĨাāĻ•া āϞিāĻ™্āĻ•āĻ—ুāϞিāϰ āĻĢāϞে āĻāĻ•āϟি āĻ›োāϟ āĻ•āĻŽিāĻļāύ āĻšāϤে āĻĒাāϰে āϝāĻĻি āφāĻĒāύি āĻ•োāύāĻ“ āĻ…āϤিāϰিāĻ•্āϤ āĻ–āϰāϚ āĻ›াāĻĄ়াāχ āĻĒ্āϰāϏ্āϤাāĻŦিāϤ āĻĒāĻŖ্āϝāϟি āĻ•্āϰāϝ় āĻ•āϰāϤে āϚাāύ। āĻāϟি āφāĻŽাāĻĻেāϰ āĻ—āĻŦেāώāĻŖা āĻāĻŦং āϏāĻŽ্āĻĒাāĻĻāĻ•ীāϝ় āĻĻāϞāĻ•ে āϏāĻŽāϰ্āĻĨāύ āĻ•āϰাāϰ āĻĻিāĻ•ে āϝাāϝ়। āĻ…āύুāĻ—্āϰāĻš āĻ•āϰে āϜেāύে āϰাāĻ–ুāύ āφāĻŽāϰা āĻļুāϧুāĻŽাāϤ্āϰ āωāϚ্āϚ-āĻŽাāύেāϰ āĻĒāĻŖ্āϝেāϰ āϏুāĻĒাāϰিāĻļ āĻ•āϰি।

āĻĻাāĻŦিāϤ্āϝাāĻ—:

āĻ…āύুāĻ—্āϰāĻš āĻ•āϰে āĻŦুāĻুāύ āϝে āĻāĻ–াāύে āĻĒ্āϰāĻ•াāĻļিāϤ āϝেāĻ•োāύ āĻĒāϰাāĻŽāϰ্āĻļ āĻŦা āύিāϰ্āĻĻেāĻļিāĻ•া āϞাāχāϏেāύ্āϏāĻĒ্āϰাāĻĒ্āϤ āϏ্āĻŦাāϏ্āĻĨ্āϝāϏেāĻŦা āĻĒ্āϰāĻĻাāύāĻ•াāϰী āĻŦা āĻĒ্āϰāϤ্āϝāϝ়িāϤ āφāϰ্āĻĨিāĻ• āωāĻĒāĻĻেāώ্āϟাāϰ āĻ•াāĻ› āĻĨেāĻ•ে āϏāĻ িāĻ• āϚিāĻ•িā§ŽāϏা āĻŦা āφāϰ্āĻĨিāĻ• āĻĒāϰাāĻŽāϰ্āĻļেāϰ āϜāύ্āϝ āĻĻূāϰāĻŦāϰ্āϤীāĻ­াāĻŦে āĻŦিāĻ•āϞ্āĻĒāĻ“ āύāϝ়। āφāĻĒāύি āϝāĻĻি āĻ“āώুāϧ āĻŦ্āϝāĻŦāĻšাāϰ āĻ•āϰেāύ āĻŦা āωāĻĒāϰে āĻļেāϝ়াāϰ āĻ•āϰা āĻĒāϰ্āϝাāϞোāϚāύাāϰ āĻŦিāĻŦāϰāĻŖ āĻ…āύুāϏāϰāĻŖ āĻ•āϰে āωāĻĻ্āĻŦেāĻ— āĻĨাāĻ•ে āϤāĻŦে āĻ•েāύাāϰ āϏিāĻĻ্āϧাāύ্āϤ āύেāĻ“āϝ়াāϰ āφāĻ—ে āĻāĻ•āϜāύ āĻĒেāĻļাāĻĻাāϰ āϚিāĻ•িāϤ্āϏāĻ• āĻŦা āφāϰ্āĻĨিāĻ• āĻĒāϰাāĻŽāϰ্āĻļāĻĻাāϤাāϰ āϏাāĻĨে āĻĒāϰাāĻŽāϰ্āĻļ āĻ•āϰāϤে āĻ­ুāϞāĻŦেāύ āύা। āĻĒৃāĻĨāĻ• āĻĢāϞাāĻĢāϞ āĻĒāϰিāĻŦāϰ্āϤিāϤ āĻšāϤে āĻĒাāϰে āĻāĻŦং āύিāĻļ্āϚিāϤ āĻ•āϰা āĻšāϝ় āύা āĻ•াāϰāĻŖ āĻāχ āĻĒāĻŖ্āϝāĻ—ুāϞিāϰ āĻŦিāώāϝ়ে āĻŦিāĻŦৃāϤিāĻ—ুāϞি āĻĢুāĻĄ āĻ…্āϝাāύ্āĻĄ āĻĄ্āϰাāĻ— āĻ…্āϝাāĻĄāĻŽিāύিāϏ্āϟ্āϰেāĻļāύ āĻŦা āĻšেāϞāĻĨ āĻ•াāύাāĻĄা āĻĻ্āĻŦাāϰা āĻŽূāϞ্āϝাāϝ়āύ āĻ•āϰা āĻšāϝ়āύি। āĻāχ āĻĒāĻŖ্āϝāĻ—ুāϞিāϰ āĻ•াāϰ্āϝāĻ•াāϰিāϤা āĻāĻĢāĻĄিāĻ, āĻŦা āĻšেāϞāĻĨ āĻ•াāύাāĻĄা āĻ…āύুāĻŽোāĻĻিāϤ āĻ—āĻŦেāώāĻŖা āĻĻ্āĻŦাāϰা āύিāĻļ্āϚিāϤ āĻ•āϰা āĻšāϝ়āύি। āĻāχ āĻĒāĻŖ্āϝāĻ—ুāϞি āĻ•োāύāĻ“ āϰোāĻ— āύিāϰ্āĻŖāϝ়, āϚিāĻ•িāϤ্āϏা, āύিāϰাāĻŽāϝ় āĻŦা āĻĒ্āϰāϤিāϰোāϧ āĻ•āϰাāϰ āωāĻĻ্āĻĻেāĻļ্āϝে āύāϝ় āĻāĻŦং āĻ•োāύāĻ“ āϧāϰāĻŖেāϰ āĻ…āϰ্āĻĨ-āϧāύী āϏ্āĻ•িāĻŽ āĻĒ্āϰāĻĻাāύ āĻ•āϰে āύা। āĻŽূāϞ্āϝ āύিāϰ্āϧাāϰāĻŖেāϰ āĻ­ুāϞেāϰ āϜāύ্āϝ āĻĒāϰ্āϝাāϞোāϚāĻ• āĻĻাāϝ়ী āύāϝ়। āϚূāĻĄ়াāύ্āϤ āĻŽূāϞ্āϝেāϰ āϜāύ্āϝ āĻĒāĻŖ্āϝ āĻŦিāĻ•্āϰāϝ় āĻĒৃāώ্āĻ া āϚেāĻ• āĻ•āϰুāύ.

āĻāχ āύিāĻŦāύ্āϧāϟি āϏ্āĻĒāύāϏāϰ āĻ•āύ্āϟেāύ্āϟ. āϟাāχāĻŽāϏ āĻ…āĻĢ āχāϏāϰাāϝ়েāϞ āĻĻ্āĻŦাāϰা āĻŦিāϜ্āĻžাāĻĒāύāĻĻাāϤাāϰ āĻĒāĻŖ্āϝ āĻŦা āĻĒāϰিāώেāĻŦাāĻĻিāϰ āĻ•োāύ āĻ…āύুāĻŽোāĻĻāύ, āĻŦাāϏ্āϤāĻŦ āĻŦা āωāĻš্āϝ, āωāĻĻ্āĻĻেāĻļ্āϝ āύāϝ়। āϟাāχāĻŽāϏ āĻ…āĻĢ āχāϏāϰাāϝ়েāϞ āϏāĻŽ্āĻĒাāĻĻāĻ•ীāϝ় āĻĻāϞ āĻāχ āύিāĻŦāύ্āϧে āĻ…āĻŦāĻĻাāύ āϰাāĻ–ে āύি।

āφāĻĒāύাāϰ āϚোāĻ–āĻ•ে āϏুāϏ্āĻĨ āϰাāĻ–াāϰ āϜāύ্āϝ āϏেāϰা 10āϟি āϏেāϰা āĻ­িāϟাāĻŽিāύ āĻāĻŦং āĻĒুāώ্āϟি

Post a Comment (0)
Previous Post Next Post